Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Lenalidomide treatment of POEMS syndrome

Arnaud Jaccard, MD, PhD, University Hospital Limoges Dupuytren, Limoges, France, elaborates on his study which investigated the efficacy and safety of lenalidomide when treating POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasmaproliferative disorder & Skin changes) syndrome and provides an overview of the initial results. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.